TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.76+0.00 (+0.07%)
Close on Nov 17, 2026Market cap $34.21MP/E –Yield –
TELA Bio total assets
Total assets on the balance sheet at the end of each period.
TELA Bio's total assets was $59.74M at Jun 30, 2026. For fiscal 2025 it was $81.42M, down 6.0% from the year before. The highest annual figure on record is $86.57M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.42M | -6.0% |
| FY2024 | Dec 31, 2024 | $86.57M | +10.9% |
| FY2023 | Dec 31, 2023 | $78.05M | +15.0% |
| FY2022 | Dec 31, 2022 | $67.86M | +8.5% |
| FY2021 | Dec 31, 2021 | $62.54M | -27.7% |
| FY2020 | Dec 31, 2020 | $86.46M | +27.3% |
| FY2019 | Dec 31, 2019 | $67.92M | +149.5% |
| FY2018 | Dec 31, 2018 | $27.23M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $59.74M | -11.5% |
| Q1 FY2026 | Mar 31, 2026 | $69.89M | -9.5% |
| Q4 FY2025 | Dec 31, 2025 | $81.42M | -6.0% |
| Q3 FY2025 | Sep 30, 2025 | $61.59M | +16.2% |
| Q2 FY2025 | Jun 30, 2025 | $67.54M | +12.2% |
| Q1 FY2025 | Mar 31, 2025 | $77.25M | +7.5% |
| Q4 FY2024 | Dec 31, 2024 | $86.57M | +10.9% |
| Q3 FY2024 | Sep 30, 2024 | $53.02M | -39.3% |
| Q2 FY2024 | Jun 30, 2024 | $60.20M | -36.2% |
| Q1 FY2024 | Mar 31, 2024 | $71.84M | +22.2% |
| Q4 FY2023 | Dec 31, 2023 | $78.05M | +15.0% |
| Q3 FY2023 | Sep 30, 2023 | $87.32M | +9.7% |
| Q2 FY2023 | Jun 30, 2023 | $94.39M | +83.9% |
| Q1 FY2023 | Mar 31, 2023 | $58.79M | +6.2% |
| Q4 FY2022 | Dec 31, 2022 | $67.86M | +8.5% |
| Q3 FY2022 | Sep 30, 2022 | $79.56M | +15.6% |
| Q2 FY2022 | Jun 30, 2022 | $51.33M | -30.4% |
| Q1 FY2022 | Mar 31, 2022 | $55.36M | -29.3% |
| Q4 FY2021 | Dec 31, 2021 | $62.54M | -27.7% |
| Q3 FY2021 | Sep 30, 2021 | $68.81M | -25.5% |
| Q2 FY2021 | Jun 30, 2021 | $73.80M | -24.3% |
| Q1 FY2021 | Mar 31, 2021 | $78.32M | +33.1% |
| Q4 FY2020 | Dec 31, 2020 | $86.46M | +27.3% |
| Q3 FY2020 | Sep 30, 2020 | $92.35M | +239.2% |
| Q2 FY2020 | Jun 30, 2020 | $97.55M | – |
| Q1 FY2020 | Mar 31, 2020 | $58.84M | – |
| Q4 FY2019 | Dec 31, 2019 | $67.92M | – |
| Q4 FY2018 | Dec 31, 2018 | $27.23M | – |
See a number that looks wrong?